← ANALYST RATINGS · TIPRANKS
Trulieve Cannabis (TRLV): analyst forecast and price target
Analyst consensus
0 Buy0 Hold0 Sell
Ratings of 0 analysts in the last 3 months · top analysts only12-month forecast
Based on 0 price targets given in the last 3 months, the average target is —, the highest —, the lowest —. The average is — from the last price of $10.01.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Bill Kirk★★★★★★★★★★#12248 · hits 38% · avg −7.9% | Roth MKM | $19.00 | Buy | +89.8% | Reiterated | 05.10.26on TipRanks 09:30 | −1.3%next day −0.5% · 5 days −2.9% | ↗ |
| AI xAi Drug Manufacturers - Specialty and GenericxAI Grok-3 | TipRanks - xAI | $13.00 → $11.50−11.5% | Hold | +14.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| AI DeepSeek Drug Manufacturers - Specialty and GenericDeepSeek R1-0528 | TipRanks - DeepSeek | $13.00 → $11.50−11.5% | Hold | +14.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| AI OpenAI Drug Manufacturers - Specialty and GenericOpenAI 4o | TipRanks - OpenAI | $13.00 → $11.50−11.5% | Hold | +14.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| AI Anthropic Drug Manufacturers - Specialty and GenericAnthropic Opus-4.1 | TipRanks - Anthropic | $13.00 → $11.00−15.4% | Hold | +9.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| AI Google Drug Manufacturers - Specialty and GenericGemini 2.5Pro | TipRanks - Google | $13.50 → $11.50−14.8% | Hold | +14.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Drug Manufacturers - Specialty and GenericPerPlexity SonarPro | TipRanks - PerPlexity | $13.50 → $11.50−14.8% | Hold | +14.9% | Reiterated | 01.10.26on TipRanks 10:05 | — | |
| Gabrielle Ingoglia | Cantor Fitzgerald | $15.00 | Buy | +49.9% | Reiterated | 29.09.26on TipRanks Sep 30 21:30 | +0.8%next day −12.0% · 5 days −16.1% | ↗ |
| Neal Gilmer★★★★★★★★★★#9727 · hits 43% · avg −0.7% | Haywood | $17.25 | Buy | +72.3% | Reiterated | 07.08.26on TipRanks 18:05 | +3.8%next day +2.7% · 5 days +4.3% | ↗ |
| Aaron Grey★★★★★★★★★★#11931 · hits 35% · avg −6.2% | Alliance Global Partners | $20.00 | Buy | +99.8% | Reiterated | 07.08.26on TipRanks 17:10 | +3.8%next day +2.7% · 5 days +4.3% | ↗ |
| Luke Hannan★★★★★★★★★★#1868 · hits 44% · avg +12.1% | Canaccord Genuity | $19.64 | Buy | +96.2% | Reiterated | 08.05.26on TipRanks Jun 11 09:05 | −6.3%next day −3.4% · 5 days −17.7% | ↗ |
| Frederico Gomes★★★★★★★★★★#10704 · hits 49% · avg −3.9% | ATB Cormark Capital Markets | $10.52 | Buy | +5.1% | Reiterated | 27.02.26on TipRanks Jun 11 09:05 | −1.2%next day −6.2% · 5 days +5.4% | ↗ |
| Russell Stanley★★★★★★★★★★#1014 · hits 42% · avg +22.8% | Beacon | $14.03 | Buy | +40.2% | Reiterated | 22.12.25on TipRanks Jun 11 09:05 | −11.9%next day +3.2% · 5 days +15.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Trulieve Cannabis
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 05.10.26: target $17.81 at a price of $10.72 (+66.2%); now: $17.81 at $10.01 (+77.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.09 (from $0.02 to $0.12). Last quarter: $-2.11.
Sales
Next quarter’s sales estimate — $222M (from $221M to $222M). Last quarter: $271M.
Best top-analyst consensus in the sector · Healthcare
About Trulieve Cannabis
- CEO: Kimberly A. Rivers
- Employees: 5,000
- 3494 Martin Hurst Road, Tallahassee, FL, 32312, US
- www.trulieve.com
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Data from the stock’s TipRanks forecast page, read 55 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗